Comparing inflammation markers from dried blood spots and standard blood draws
Official title: Analysis of Inflammatory Biomarker Changes in Dry Blood Spot Versus Venous Blood Samples
Run by McGill University Health Centre/Research Institute of the McGill University Health Centre · NCT07435285 · Data updated 2026-11-12
This will see if finger‑prick dried blood spot samples can measure inflammation markers as accurately as standard venous blood draws in adults receiving a planned vaccine or other scheduled stressor.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | McGill University Health Centre/Research Institute of the McGill University Health Centre Academic / other |
| Locations | 1 site (Montreal, Quebec) |
| Status | Recruiting |
| Started | January 15, 2026 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | March 27, 2026 |
| Trial ID | NCT07435285 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 and older who are planning to receive a seasonal vaccine or have another scheduled acute stressor and who do not have recent infectious symptoms or recent acute worsening of chronic disease.
✕Probably not a fit
People with recent infection symptoms, recent use of certain recreational drugs, recent acute worsening of chronic conditions, a contraindication to the planned vaccine, or those not undergoing a planned stressor are unlikely to benefit from participating.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults planning to receive a seasonal vaccine or another planned acute stressor provide paired dried blood spot (DBS) and venous blood samples before and after the event to capture changes in inflammatory biomarkers. Investigators measure and compare concentrations and changes in biomarkers in DBS versus matched venous samples to determine agreement and reliability. The protocol excludes people with recent infectious symptoms, recent substance use, or recent acute worsening of chronic disease to avoid confounding inflammation signals. Results will inform whether DBS can serve as a practical alternative to clinic-based venous sampling for future research and decentralized monitoring.
Why it matters
Potential benefit: If successful, DBS sampling could allow easier at‑home or remote collection for monitoring inflammation, reducing the need for clinic visits and venous draws.
How similar studies have gone: Previous work has shown DBS can reliably measure some inflammation markers such as CRP, but results are variable for certain cytokines, so DBS is promising but not yet universally validated for all inflammatory biomarkers.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Men or women aged ≥18 years, who are planning to receive a seasonal vaccine OR have a scheduled acute stressor\*. Exclusion Criteria: * Any infectious symptoms (fever, cough, rhinorrhea, sore throat, diarrhea, loss of smell or taste) within the previous 7 days * Any self-reported active/recent use of cocaine, injection drugs, or amphetamines * Acute worsening of a known chronic health condition within the previous 30 days (e.g., of IBD, COPD, asthma, rheumatologic disease) * Known severe allergy or intolerance to the planned vaccine * Contraindication to the vaccine received, if applicable \*List of possible scheduled acute stressors include: * Hard exercise (incl. 10km run or longer, high-intensity interval training, or comparable endurance activity) * Social event with moderate alcohol consumption * Planned change in medication dose and/or frequency of use * Onset of menstruation (day 1) * Other pre-planned stressors expected to elicit an inflammatory response
Where it's running
-
Research Institute of the McGill University Health Centre
Montreal, Quebec, Canada Recruiting
Study contacts
- Principal investigator: Emily G. McDonald, MD MSc — McGill University Health Centre/Research Institute of the McGill University Health Centre
- Study coordinator: Kristen Moran, BSc.
- Email: cpau.med@mcgill.ca
- Phone: 514-934-1934
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Predicting Heart Muscle Recovery After CTO Revascularization
This study looks at whether blood tests and stress echo measurements can predict which patients with CTO will regain heart muscle function after a revascularization procedure.
-
Collagen and omega-3 supplements in middle-aged women
This study tests whether taking collagen and omega-3s together improves joint pain, fatigue, sleep, and overall wellbeing in healthy women aged 35–65 compared with a placebo over 8 weeks.
-
Two Different Therapeutic Distractions Used During Blood Draw for Children Aged 5–7
This study tests whether two distraction methods during blood sampling can reduce pain, fear, and anxiety in 5–7 year-olds compared with routine care.
-
Creatine or placebo to test effects on cognition, muscle strength, and body composition in middle-aged women
This study tests whether taking creatine daily for 8 weeks improves thinking, strength, fatigue, and body composition in healthy middle-aged women compared to a placebo.
-
How common dietary fats change gut bacteria and metabolic markers
We will test whether replacing part of daily fat with butter, coconut oil, olive oil, or sunflower oil for two weeks changes gut bacteria and related blood markers in healthy adults aged 20–50.
-
Ginger capsules for inflammation, oxidative stress, and blood vessel health
This trial will test whether taking a daily ginger capsule for 60 days can lower inflammation and oxidative stress and improve blood vessel function in adults with excess body fat.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.